Variations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorder

2017-06-292026-03-272017-06-292008Alberto Darío Ramírez González0924-977X10.1016/j.euroneuro.2008.08.001https://doi.org/10.1016/j.euroneuro.2008.08.001https://repositorio.inprf.gob.mx/handle/123456789/5248engacceso cerradoAdultAnalysis of VarianceAntidepressive Agents-therapeutic useCytokines-bloodDepressive Disorder, Major-bloodDepressive Disorder, Major-drug therapyEnzyme-Linked Immunosorbent AssayFemaleHumansHydrocortisone-bloodLongitudinal StudiesMalePsychiatric Status Rating ScalesRadioimmunoassay-methodsRetrospective StudiesSerotonin Uptake Inhibitors-therapeutic useTime FactorsYoung AdultVariations in circulating cytokine levels during 52 week course of treatment with SSRI for major depressive disorderarticle1873-786212Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz917-924Netherlands18